Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate whether long-term oral administration of
Staphylococcus albicans tablets can significantly reduce the number of acute exacerbations in
patients with bronchiectasis. Secondary objective is to explore whether long-term oral
administration of Staphylococcus albicans tablets can reduce the risk of hospitalization in
patients with bronchiectasis and whether it can improve the quality of life of patients.
Other purpose is to explore the regulatory effect of long-term oral administration of
Staphylococcus albicans tablets on the immune function of patients with bronchiectasis.